Abstract
AbstractObjectiveThis study aimed to investigate and improve the usefulness of the 48‐hour BH4 loading test and to assess genotype for BH4 responsiveness prediction, using the new definition of BH4 responsiveness from the European guidelines, as well as an amended definition.MethodApplying the definition of the European guidelines (≥100% increase in natural protein tolerance) and an amended definition (≥100% increase in natural protein tolerance or tolerating a safe natural protein intake) to a previous dataset, we first assessed the positive predictive value (PPV) of the 48‐hour BH4 loading test using a cutoff value of 30%. Then, we tried to improve this PPV by using different cutoff values and separate time points. Last, using the BIOPKU database, we compared predicted BH4 responsiveness (according to genotype) and genotypic phenotype values (GPVs) in BH4‐responsive and BH4‐unresponsive patients.ResultsThe PPV of the 48‐hour loading test was 50.0% using the definition of the European guidelines, and 69.4% when applying the amended definition of BH4 responsiveness. Higher cutoff values led to a higher PPV, but resulted in an increase in false‐negative tests. Parameters for genotype overlapped between BH4‐responsive and BH4‐unresponsive patients, although BH4 responsiveness was not observed in patients with a GPV below 2.4.ConclusionThe 48‐hour BH4 loading test is not as useful as previously considered and cannot be improved easily, whereas genotype seems mainly helpful in excluding BH4 responsiveness. Overall, the definition of BH4 responsiveness and BH4 responsiveness testing require further attention.
Topics

No keywords indexed for this article. Browse by subject →

Cited By
13
Phenylketonuria

Francjan J. van Spronsen, Nenad Blau · 2021

Nature Reviews Disease Primers
Metrics
13
Citations
16
References
Details
Published
Nov 20, 2019
Vol/Issue
43(2)
Pages
244-250
License
View
Funding
Rare Disease Foundation
BioMarin Pharmaceutical
Alexion Pharmaceuticals
National PKU Alliance
Vitaflo
Nutricia Research Foundation
Cite This Article
Roeland A. F. Evers, Annemiek M. J. van Wegberg, Karen Anjema, et al. (2019). The first European guidelines on phenylketonuria: Usefulness and implications for BH4 responsiveness testing. Journal of Inherited Metabolic Disease, 43(2), 244-250. https://doi.org/10.1002/jimd.12173